http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18058052

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
issn 1478-6362
1478-6354
issueIdentifier 3
pageRange R95-
publicationName Arthritis Research & Therapy
startingPage R95
bibliographicCitation Tebib J, Mariette X, Bourgeois P, Flipo R, Gaudin P, Le Loët X, Gineste P, Guy L, Mansfield CD, Moussy A, Dubreuil P, Hermine O, Sibilia J. Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study. Arthritis Research & Therapy. 2009 Jun 23;11(3):r95. doi: 10.1186/ar2740.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65da6cb61283a164d5e8a5df1260c52f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_659203ea617fca9e7d9a1759445ddaaf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df5ea5c86ffafad9e6ecb5dc8cb3120e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_501f4afcda95b48b32f1afc8b5827966
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89afccc9cbf5a08e252dd59397a94c11
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e3f6d1d5eeaca91b2d8fef3da201407
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1f83b06d3c374c2313369dac3cb19fa
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fee527f26fd66de3995e3bfcaea014a7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc4174e5afb349ca115f5e1cee1d37e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53a7e89104d604207c5501ddf77767d1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d88fa0d28ab0f2b92e2ed88431f3362
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0653f6ba87011109f0483cd472d74bcd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0119cd3acd0ddaaa591c3d173a2c3dd2
date 2009-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/19549290
https://pubmed.ncbi.nlm.nih.gov/PMC2714151
https://doi.org/10.1186/ar2740
isPartOf https://portal.issn.org/resource/ISSN/1478-6354
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30289
https://portal.issn.org/resource/ISSN/1478-6362
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study
discusses http://id.nlm.nih.gov/mesh/M0021333
http://id.nlm.nih.gov/mesh/M0002327
http://id.nlm.nih.gov/mesh/M0016885
http://id.nlm.nih.gov/mesh/M0518458
http://id.nlm.nih.gov/mesh/M0018233
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a7939d043567ee90a9f1febb314e563d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ffa044f5d18974a3264c23a5e1e06217
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10074640
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129939125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129476173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID178102284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245421274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127658045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128754351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID404770711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595

Total number of triples: 57.